NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Well what I have heard is that Gilead was on board in fluffing the MC up for Kite prior to the acquiring. A higher acquiring price must be earned back and can thus justify a higher sales price and thus higher revenue. CEOs are ofcourse short term accounted for their revenue performance which ofcourse increases the MC of the acquiring company. So now Gilead could justify the high sales price for Kites products to all the insurance companies/counties because of the return on their investment acquiring Kite. Is what I have read.